Design, Synthesis, and Computational Studies of Novel N-(Substituted phenyl)-3-(5-((naphthalen-2-yloxy)methyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetamides as Potent Acetylcholinesterase Inhibitors
Open Access
- 29 September 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (39) , 45191-45203
Abstract
The current studies elaborate the synthesis of some new N-(substituted phenyl)-3-(5-((naphthalen-2-yloxy)methyl)-4-phenyl-4H-1,2,4-triazol-3-ylthio)acetamides (8a–8h). This novel synthesis was accomplished by a well-explained protocol and structural corroboration of derivatives with the help of infrared, electron ionization mass spectrometry, and 1H nuclear magnetic resonance (NMR) and 13C NMR spectral techniques. The in vitro inhibitory potential of newly synthesized acetamides was evaluated against acetylcholinesterase enzyme, and it was explored that all the compounds showed relatively comparable potential as compared to donepezil (IC50 = 0.454 ± 0.076) used as a standard. Among the unique group of these triazoles, compound 8a depicted the maximum inhibition (IC50 = 0.697 ± 0.43). With the outcomes obtained through inhibitory investigation, it was envisaged that these compounds might serve as promising acetylcholinesterase inhibitors and might also lead to a further research gateway for getting safe and nontoxic medicinal derivatives for dealing with acetylcholinesterase-related deformities. Likewise, their bioactivity results were further validated through computational density functional theory and docking analysis to develop the structure–activity relationship finding factors responsible for variable potential through engineering structures with different chemical entities.Keywords
This publication has 58 references indexed in Scilit:
- Nitrogen‐containing flavonoid and their analogs with diverse B‐ring in acetylcholinesterase and butyrylcholinesterase inhibitionDrug Development Research, 2020
- Structure–activity study of fluorine or chlorine‐substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibitionDrug Development Research, 2019
- Anti-Dementia Drugs and Co-Medication Among Patients with Alzheimer’s DiseaseDrugs & Aging, 2014
- Alzheimer’s Disease2012
- Dementia incidence continues to increase with age in the oldest old: The 90+ studyAnnals of Neurology, 2010
- 1,2,4-Triazoles2008
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Pharmacokinetics and Drug Interactions of Cholinesterase Inhibitors Administered in Alzheimer's DiseasePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1998
- Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development—A study of molecular formsNeurochemistry International, 1992
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961